Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60.9M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
12.6M
-
Shares change
-
-98.2K
-
Total reported value, excl. options
-
$25.6M
-
Value change
-
-$258K
-
Number of buys
-
3
-
Number of sells
-
-9
-
Price
-
$2.04
Significant Holders of Equillium, Inc. - Common Stock (EQ) as of Q2 2022
28 filings reported holding EQ - Equillium, Inc. - Common Stock as of Q2 2022.
Equillium, Inc. - Common Stock (EQ) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.6M shares
of 60.9M outstanding shares and own 20.74% of the company stock.
Largest 10 shareholders include Decheng Capital Management III (Cayman), LLC (4.45M shares), VICTORY CAPITAL MANAGEMENT INC (3.58M shares), FRANKLIN RESOURCES INC (895K shares), VANGUARD GROUP INC (845K shares), Samsara BioCapital, LLC (616K shares), TANG CAPITAL MANAGEMENT LLC (600K shares), Cota Capital Management, LLC (562K shares), DEUTSCHE BANK AG\ (356K shares), True North Advisors, LLC (176K shares), and GEODE CAPITAL MANAGEMENT, LLC (159K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.